Cited by 2,049Multiple Sclerosis Research StudiesViral-associated cancers and disordersCytomegalovirus and herpesvirus research

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Bjornevik, Kjetil, Cortese, Marianna, Healy, Brian C., Kuhle, Jens, Mina, Michael J., Leng, Yumei, Elledge, Stephen J., Niebuhr, David W., Scher, Ann I., Munger, Kassandra L., Ascherio, Alberto·2022·Science

DOI 10.1126/science.abj8222

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system of unknown etiology. We tested the hypothesis that MS is caused by Epstein-Barr virus (EBV) in a cohort comprising more than 10 million young adults on active duty in the US military, 955 of whom were diagnosed with MS during their period of service. Risk of MS increased 32-fold after infection with EBV but was not increased after infection with other viruses, including the similarly transmitted cytomegalovirus. Serum levels of neurofilament light chain, a biomarker of neuroaxonal degeneration, increased only after EBV seroconversion. These findings cannot be explained by any known risk factor for MS and suggest EBV as the leading cause of MS.

Integrity signals

Registry

Crossref · 10.1126/science.abj8222

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sensitivity analysis in observational research: Introducing the E-value
VanderWeele, T. J., & Ding, P. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2607 · Cited by 6,350
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Multiple sclerosis
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491
The Immune Epitope Database (IEDB): 2018 update
Vita, R., Mahajan, S., Overton, J. A., Dhanda, S. K., Martini, S. R., Cantrell, J. R., Wheeler, D. K., Sette, A., & Peters, B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1006 · Cited by 2,194
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Hauser, S. L., Bar-Or, A., Comi, G., Giovannoni, G., Hartung, H.-P., Hemmer, B., Lublin, F., Montalban, X., Rammohan, K. W., Selmaj, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1601277 · Cited by 2,021
Neurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Negative Controls: A Tool for Detecting Confounding and Bias in Observational Studies
Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181d61eeb · Cited by 1,583
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T. P., Barcellos, L. F., & Alfredsson, L. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,263
Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis
Disanto, G., Barro, C., Benkert, P., Naegelin, Y., Schädelin, S., Giardiello, A., Zecca, C., Blennow, K., Zetterberg, H., Leppert, D., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24954 · Cited by 1,164
Epstein-Barr virus: exploiting the immune system
Thorley‐Lawson, D. A. (2001) · Nature reviews. Immunology · doi:10.1038/35095584 · Cited by 942

Show all 51 references

Sorted by citations

Items 901–1,000 of 1,001

Coeliac disease as a model for understanding multiple sclerosis
Drosu, N. C., Bjørnevik, K., Cortese, M., Levy, M., & Sollid, L. M. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01025-y · Cited by 6
Self-citation
Preceding hepatitis B virus infection is highly prevalent in patients with neuromyelitis optica spectrum disorder in Taiwan
Yang, W.-Y. O., Tsai, Y., Liu, Y., Wang, Y.-F., Hsiao, C.-T., Lai, K., Lee, Y., & Liao, Y. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105923 · Cited by 6
TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice
Zhang, X., Chen, Y., Wang, S., Zhong, L., Xiang, Z., Zhang, X., Zhang, S., Zhou, X., Zhang, W., Zhou, Y., et al. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2412640 · Cited by 6
“No immune competition was observed at the current dose used for the vaccination. gH/gL is the component of the core fusion machinery necessary for EBV infection in both B and epithelial cells [34].”
Background
Genome-wide CRISPR screens identify CLC-2 as a drug target for anti-herpesvirus therapy: tackling herpesvirus drug resistance
Yang, F., Wei, N., Cai, S., Liu, J., Lan, Q., Zhang, H., Shang, L., Zheng, B., Wang, M., Liu, Y., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2627-8 · Cited by 6
“After 48 h, the cells were collected, and the expression of EBV related proteins was analyzed.”
Influential
Hidden liver-joint axis: HBV infection causes rheumatoid arthritis via TRAFD1 with imbalance of HBV X protein and trans-ferulic acid
Zhao, N., Zhang, X., Wang, X., Liu, Z., Zheng, G., Zhang, X., Schiöth, H. B., Sun, C., Wang, H., & Zhang, Y. (2024) · Virulence · doi:10.1080/21505594.2024.2422540 · Cited by 6
“Autoimmunity and viral infections are closely related [1].”
Identifying Safeguards Disabled by Epstein-Barr Virus Infections in Genomes From Patients With Breast Cancer: Chromosomal Bioinformatics Analysis
Friedenson, B. (2024) · JMIRx Med · doi:10.2196/50712 · Cited by 6
High heterogeneity of cross-reactive immunoglobulins in multiple sclerosis presumes combining of B-cell epitopes for diagnostics: a case-control study
Ovchinnikova, L. A., Eliseev, I. E., Dzhelad, S. S., Simaniv, T. O., Klimina, K. M., Mv, I., Ilina, E. N., Zakharova, M. N., Illarioshkin, S. N., Rubtsov, Y. P., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1401156 · Cited by 6
Vaccination in multiple sclerosis: Tackling challenges and paving the way for effective immunization
Carvajal, R., Tur, C., Borràs-Bermejo, B., Saylor, D. R., Montalbán, X., Tintoré, M., & Otero‐Romero, S. (2025) · Multiple Sclerosis Journal · doi:10.1177/13524585251318513 · Cited by 6
“77 Anti-EBV vaccines, currently in clinical trials, target viral glycoproteins to prevent EBV infection.”
Chemokines as therapeutic targets for multiple sclerosis: a spatial and chronological perspective
Arimitsu, N. N., Witkowska, A., Ohashi, A., Miyabe, C., & Miyabe, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1547256 · Cited by 6
Investigation of the HLA locus in autopsy-confirmed progressive supranuclear palsy
Wang, J., Forrest, S. L., Dasari, S., Tanaka, H., Rogaeva, E. A., Tartaglia, M. C., Fox, S. H., Lang, A. E., Kalyaanamoorthy, S., & Kovács, G. G. (2025) · Immunobiology · doi:10.1016/j.imbio.2025.152892 · Cited by 5
FABP7 is increased in progressive multiple sclerosis and induces a pro-inflammatory phenotype in monocytes through a glycolytic switch
Patel, R. P., King, D. A., LaBarre, B. A., Lokhande, H. A., Caefer, D., Varghese, J. F., Warner, K., Bouffard, M. A., Saxena, S., Zhirova, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60747-9 · Cited by 6
“However, genetic, lifestyle, and environmental factors are recognized risk factors for the disease 3 – 7 .”
Linking Epstein-Barr virus infection to multiple sclerosis
Bordon, Y. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00686-4 · Cited by 6
Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach
Immovilli, P., Morelli, N., Terracciano, C., Rota, E., Marchesi, E., Vollaro, S., Mitri, P. D., Zaino, D., Bazzurri, V., & Guidetti, D. (2022) · Neurology International · doi:10.3390/neurolint14020030 · Cited by 6
Epstein–Barr Virus (EBV) and Multiple Sclerosis Disease: A Biomedical Diagnosis
Alanazi, A. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/3762892 · Cited by 6
High prevalence of low-allele-fraction somatic mutations in STAT3 in peripheral blood CD8+ cells in multiple sclerosis patients and controls
Valori, M., Lehikoinen, J., Jansson, L., Clancy, J., Lundgren, S., Mustjoki, S. M., & Tienari, P. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278245 · Cited by 6
Hypothesis of a potential BrainBiota and its relation to CNS autoimmune inflammation
Elkjaer, M. L., Simon, L. M., Frisch, T., Bente, L.-M., Kacprowski, T., Thomassen, M., Reynolds, R., Baumbach, J., Röttger, R., & Illés, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1043579 · Cited by 6
Impact of Misdiagnosis in Case-Control Studies of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Malato, J., Graça, L., & Sepúlveda, N. (2023) · Diagnostics · doi:10.3390/diagnostics13030531 · Cited by 8
Clostridium epsilon toxin is excessive in multiple sclerosis and provokes multifocal lesions in mouse models
Reder, A. T. (2023) · Journal of Clinical Investigation · doi:10.1172/jci169643 · Cited by 6
Higher frequency of Human herpesvirus-6 (HHV-6) viral DNA simultaneously with low frequency of Epstein-Barr virus (EBV) viral DNA in a cohort of multiple sclerosis patients from Rio de Janeiro, Brazil
Pereira, J. G., Leon, L. A. A., de Almeida, N. A. A., Raposo-Vedovi, J. V., Fontes-Dantas, F. L., Farinhas, J. G. D., Pereira, V. C. S. R., Alves‐Leon, S. V., & de Paula, V. S. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104747 · Cited by 7
Generation of an Open-Access Patient-Derived iPSC Biobank for Amyotrophic Lateral Sclerosis Disease Modelling
Hedges, E. C., Cocks, G. D., Shaw, C. E., & Nishimura, A. L. (2023) · Genes · doi:10.3390/genes14051108 · Cited by 6
Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app
Mountford, S., Kahn, M., Balakrishnan, P., Jacyshyn-Owen, E., Eberl, M., Friedrich, B., Joschko, N., & Ziemssen, T. (2023) · Digital Health · doi:10.1177/20552076231173520 · Cited by 6
The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
Chunder, R., Heider, T., & Küerten, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1202006 · Cited by 8
Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in Autoimmunity
Adıgüzel, Y., Mahroum, N., Muller, S., Blank, M., Halpert, G., & Shoenfeld, Y. (2023) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-023-08962-4 · Cited by 6
Innovations in Multiple Sclerosis Care: The Impact of Artificial Intelligence via Machine Learning on Clinical Research and Decision-Making
Cartwright, J., Kipp, K., & Ng, A. V. (2023) · International Journal of MS Care · doi:10.7224/1537-2073.2022-076 · Cited by 6
The association of microbial infection and adaptive immune cell activation in Alzheimer’s disease
Clement, M. (2023) · Discovery Immunology · doi:10.1093/discim/kyad015 · Cited by 6
High-resolution DNA methylation screening of the major histocompatibility complex in multiple sclerosis
Ma, Q., Augusto, D. G., Montero-Martín, G., Caillier, S. J., Osoegawa, K., Cree, B., Hauser, S. L., Didonna, A., Hollenbach, J. A., Norman, P. J., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1326738 · Cited by 6
The risk of multiple sclerosis on the Orkney islands. A review of the search for distinctively Orcadian risks, with a hypothesis for further investigations
Gay, F. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105386 · Cited by 6
Detection of Epstein-Barr virus infection in primary junctional epithelial cell cultures
Tonoyan, L., Olivieri, C.-V., Chevalier, M., Marsault, R., & Doglio, A. (2024) · Journal of Oral Microbiology · doi:10.1080/20002297.2023.2301199 · Cited by 6
“Moreover, EBV has been associated with several autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjogren’s syndrome, systemic scleroderma [3], and multiple sclerosis, for which EBV has recently been identified as a leading cause [4].”
Background
Long-term MRI and clinical stability in an HIV-positive patient with multiple sclerosis on tenofovir: A case report
Drosu, N. C., Bjørnevik, K., Bilodeau, P., & Levy, M. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105397 · Cited by 6
Association between multiple sclerosis and urinary levels of toxic metals and organophosphates: A cross-sectional study in Israel
Armon-Omer, A., Mansor, T. M., Edelstein, M. L., Bukovetzky, E., Groisman, L., Rorman, E. G., Nov, A. S., & Shahien, R. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105445 · Cited by 6
EBV infection drives MS pathology: Yes
Aloisi, F., & Salvetti, M. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241235825 · Cited by 6
The Effects of Endosomal Toll-like Receptor Inhibitors in an EBV DNA-Exacerbated Inflammatory Bowel Disease Mouse Model
Karout, I., Salhab, Z., Sherri, N., Bitar, E. R., Borghol, A. H., Sabra, H. W., Kassem, A. H., Osman, O., Alam, C., Znait, S., et al. (2024) · Viruses · doi:10.3390/v16040624 · Cited by 6
Advancements in Machine Learning (ML): Transforming the Future of Blood Cancer Detection and Outcome Prediction
Rösler, W., Roiss, M., & Widmer, C. (2024) · healthbook TIMES Oncology Hematology · doi:10.36000/hbt.oh.2024.20.146 · Cited by 7
“8,9 In this context, AI technologies, particularly ML and DL, are revolutionizing the field of hematology-oncology, providing innovative solutions for the prediction of diagnosis, risk assessment, screening and patient prognosis estimation, as well as early diagnosis and treatment selection.”
Serum Cytokines Predict Neurological Damage in Genetically Diverse Mouse Models
Gómez, A. A. P., Karmakar, M., Carroll, R. J., Lawley, K. S., Amstalden, K. A. Z., Young, C. R., Threadgill, D. W., Welsh, C. J., & Brinkmeyer‐Langford, C. (2022) · Cells · doi:10.3390/cells11132044 · Cited by 6
EBV and multiple sclerosis: Setting the research agenda
Giovannoni, G., Vanderdonckt, P., Hartung, H., Lassmann, H., & Comi, G. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104158 · Cited by 6
Two phases of macrophages: Inducing maturation and death of oligodendrocytes in vitro co-culture
Aydınlı, F. İ., Er, S., & Kerman, B. E. (2022) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2022.109723 · Cited by 5
Thermodynamic and structural characterization of an EBV infected B-cell lymphoma transcriptome
O’Leary, C. A., Tompkins, V. S., Rouse, W. B., Nam, G., & Moss, W. N. (2022) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqac082 · Cited by 7
An EBV-associated atypical B cell signature in clinically isolated syndrome is implicated in progression of multiple sclerosisPreprint
SoRelle, E. D., Haukenfrers, E., Jain, V., Abramson, K., Hocke, E., Cooney, L. A., Harris, K. M., Zamvil, S. S., Gregory, S. G., & Luftig, M. A. (2023) · medRxiv · doi:10.1101/2023.02.26.23286433 · Cited by 6
Biological sex affects gene expression and functional variation across the human genomePreprint
Jones, A. G., Dalapati, T., Connelly, G. G., Wang, L., Schott, B. H., Roman, A. K. S., & Ko, D. C. (2024) · medRxiv · doi:10.1101/2024.09.03.24313025 · Cited by 6
Sp140L Is a Novel Herpesvirus Restriction FactorPreprint
Cable, J. M., Wongwiwat, W., Grabowski, J. C., White, R. E., & Luftig, M. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.13.628399 · Cited by 6
Spontaneous human CD8 T cell and autoimmune encephalomyelitis-induced CD4/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive multiple sclerosis humanized immune system mice
Papazian, I., Kourouvani, M., Dagkonaki, A., Gouzouasis, V., Dimitrakopoulou, L., Markoglou, N., Badounas, F., Tselios, T., Anagnostouli, M., & Probert, L. (2024) · eLife · doi:10.7554/elife.88826 · Cited by 6
Natural language processing analysis of the theories of people with multiple sclerosis about causes of their disease
Haag, C., Steinemann, N., Ajdacic‐Gross, V., Schlomberg, J. T., Ineichen, B. V., Stanikić, M., Dressel, H., Daniore, P., Roth, P., Ammann, S., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00546-3 · Cited by 5
“Established environmental factors include tobacco smoking, low vitamin D levels, low exposure to ultraviolet radiation, and infection with Epstein-Barr virus (EBV), a human lymphotropic herpes virus 3 – 8 .”
The effect of early life cytomegalovirus infection on the immune profile of children
Ekman, I., Schroderus, A., Vuorinen, T., Knip, M., Veijola, R., Toppari, J., Ilonen, J., Lempainen, J., & Kinnunen, T. T. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110330 · Cited by 6
STAT1 and herpesviruses: Making lemonade from lemons
Johansen, E. R., & Tarakanova, V. L. (2024) · Virology · doi:10.1016/j.virol.2024.110364 · Cited by 4
Effect of Epstein-Barr Virus infection on gene regulation in immune cells of patients with Immune-Mediated Diseases
Akutsu, Y., Ota, M., Itamiya, T., Mori, M., Morio, T., Yamamoto, K., Okamura, T., & Fujio, K. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103355 · Cited by 5
Novel modelling approaches to elucidate the genetic architecture of resilience to Alzheimer’s disease
Phillips, J., Dumitrescu, L. C., Archer, D. B., Regelson, A. N., Mukherjee, S., Lee, M. L., Choi, S., Scollard, P., Trittschuh, E. H., Kukull, W. A., et al. (2025) · Brain · doi:10.1093/brain/awaf106 · Cited by 6
Paediatric autoimmune uveitis is associated with intraocular antibodies against Epstein–Barr virus Nuclear Antigen 1 (EBNA-1)
Hendrikse, J., Bont, L., Schellekens, P. A. W. J. F., de Groot-Mijnes, J. D. F., de Boer, J. H., & Kuiper, J. J. W. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105681 · Cited by 5
“…conditions that are associated with gut dysbiosis or show increased seropositivity to pathogens, such as Epstein – Barr virus (EBV) in multiple sclerosis (MS) 16 – 18 or parvovirus in juvenile idiopathic arthritis (JIA), both autoimmune conditions that may manifest as non-infectious uveitis.”
Mendelian Randomization and Infection: Pitfalls and Promises
Hamilton, F., Butler‐Laporte, G., & Smith, G. D. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf251 · Cited by 5
Innate Immune Mechanisms in the Central Nervous System
Shastri, A., Yasmin, H., & Kishore, U. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-85340-1_15 · Cited by 4
Drug Repurposing and Artificial Intelligence in Multiple Sclerosis: Emerging Strategies for Precision Therapy
Villar-Delfino, P. H., Christo, P. P., & Volpe, C. M. O. (2025) · Sclerosis · doi:10.3390/sclerosis3030028 · Cited by 5
“Notably, Epstein-Barr virus (EBV) infection has emerged as a strong environmental risk factor, associated with a 32-fold increased risk of MS [10,11].”
Immunosenescence in multiple sclerosis: New insights and clinical implications
Laroni, A., Vigo, T., Inglese, M., & Uccelli, A. (2025) · Multiple Sclerosis Journal · doi:10.1177/13524585251367611 · Cited by 6
“62 In the cerebrospinal fluid (CSF), lower number of immune cells is observed in progressive MS upon aging, compared to younger patients with progressive MS. 48 Importantly, a very recent study quantified the number of senescent cells in post-mortem brains and concentration of SASP factors in post-mortem CSF samples f…”
Influential
Discoveries beyond molecular mimicry describe how EBV drives multiple sclerosis
Steinman, L., & Zamvil, S. S. (2026) · Cell · doi:10.1016/j.cell.2025.12.047 · Cited by 5
B Cells Drive MHC Class I–Restricted CD4 T Cells to Induce Spontaneous Central Nervous System Autoimmunity
Matter, A. L., Liggitt, D., & Goverman, J. M. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200494 · Cited by 5
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
Zhong, L., Krummenacher, C., Zhang, W., Hong, J., Feng, Q., Zhao, Q., Chen, Y., Zeng, M., Zeng, Y., Xu, M., et al. (2022) · Virology Journal · doi:10.1186/s12985-022-01911-1 · Cited by 5
Could routine vaccinations prevent dementia?
Poynton-Smith, E., Orrell, M., Morley, J., & Scherrer, J. F. (2023) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5978 · Cited by 3
BCR signaling is required for posttransplant lymphoproliferative disease in immunodeficient mice receiving human B cells
Zhang, T., Cheng, R. Y.-H., Ott, A. R., Dahl, N., Suchland, E. R., Stoffers, C. M., Asher, G. D., Hou, D., Thouvenel, C. D., Hill, T. F., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adh8846 · Cited by 5
“EBV infection is associated with autoimmunity, including rheumatoid arthritis ( 25 ), systemic lupus erythematosus [SLE ( 26 , 27 )], and multiple sclerosis ( 28 , 29 ).”
Background
Intestinal MAdCAM-1 imaging as biomarker for prognostic in murine models of multiple sclerosis
Baudron, E., de Lizarrondo, S. M., Gauberti, M., Delaunay-Piednoir, B., Fournier, A. P., Vivien, D., Docagne, F., & Bardou, I. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.006 · Cited by 5
Neuroimaging Features of Cytokine-related Diseases
Kurokawa, M., Kurokawa, R., Baba, A., Gomi, T., Cho, S., Yoshioka, K., Harada, T., Kim, J., Pinarbasi, E. S., Abe, O., et al. (2024) · Radiographics · doi:10.1148/rg.230069 · Cited by 5
Infektionen und Multiple Sklerose
Heidler, F., Bopp, T., Schwab, M. G., Hoffmann, F., Schild, H., Kannler, M., Pletz, M. W., & Zettl, U. K. (2024) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2283-7401 · Cited by 5
Regulatory T cells restrict immunity and pathology in distal tissue sites following a localized infection
Graham, J. B., Swarts, J. L., Koehne, A. L., Watson, C., & Lund, J. M. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.06.007 · Cited by 5
“…result in long-term or delayed neurologic and cognitive impairment such as Epstein-Barr Virus with Multiple Sclerosis and SARS-CoV-2 with post-acute sequelae of SARS-CoV-2 infection or “long COVID”, 64,65 a deeper understanding of the potential roles of Treg in these disease processes is warranted.”
Background
Epstein–Barr virus noncoding RNA EBER1 promotes the expression of a ribosomal protein paralog to boost oxidative phosphorylation
Paudel, S., & Lee, N. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29869 · Cited by 5
“6,7 Despite long ‐ standing attention to the cellular events underlying EBV infection, we still lack treatments or vaccines for EBV ‐ related diseases.”
Herpesvirus Antibodies Are Correlated With Greater Expression of p16 in the T Cells of Humans
Noppert, G. A., Wragg, K. M., Li, C., Duchowny, K. A., Mody, L., Aiello, A. E., NYQUIST, L. V., O’Brien, M., Yung, R. L., & Goldstein, D. R. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae693 · Cited by 6
Characterization of children with early onset pediatric multiple sclerosis
Kauth, F., Bertolini, A., Wendel, E., Koukou, G., Naggar, I. E., Chung, J., Baumann, M., Schödl, C., Lechner, C., Bigi, S., et al. (2025) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2025.01.006 · Cited by 5
Tau in Multiple Sclerosis: A Review of Therapeutic Potential
Hoehne, C. L., Stüve, O., & Stopschinski, B. E. (2025) · Current Treatment Options in Neurology · doi:10.1007/s11940-024-00820-8 · Cited by 6
“While still controversial, multiple studies indicate an association between an acute infection with the Epstein-Barr virus and MS onset [5, 6].”
Environmental risk factors of late-onset multiple sclerosis: A population-based case-control study
Kasbi, N. A., Jahani, S., Ezabadi, S. G., Kohandel, K., Khodaie, F., Sahraian, A. H., Bafrani, M. A., Almasi‐Hashiani, A., Eskandarieh, S., & Sahraian, M. A. (2025) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2025.111146 · Cited by 5
Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis
Noui, Y., Zjukovskaja, C., Silfverberg, T., Ljungman, P. T., Kultima, K., Tolf, A., Tolf, T., Carlson, K. E., & Burman, J. (2025) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2024-335512 · Cited by 7
“This is of particular interest considering the crucial role that Epstein-Barr virus (EBV) infection plays in the development of MS. 21–23 Furthermore, EBV infection could well be affected by other disease-modifying therapies (DMTs) such as B-cell depleting agents, and this is yet to be explored in the context of AHSCT…”
Influential
Hypoxia in multiple sclerosis
Burtscher, J., Motl, R. W., Berek, K., Ehrenreich, H., Kopp, M., & Hohenauer, E. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103666 · Cited by 6
“Among the environmental factors that may trigger, facilitate or aggravate the disease are notable viral infections (herpes viruses), especially by the Epstein – Barr virus, which increased the hazard ratio for MS diagnosis 32fold in a recent prospective, case-controlled study [15].”
Blood parameters differentiate post COVID-19 condition from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia
Giménez-Orenga, K., Pierquin, J., Brunel, J., Charvet, B., Martín‐Martínez, E., Lemarinier, M., Fried, S., Lucas, A., Perron, H., & Oltra, E. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101058 · Cited by 6
“Similar to other viral-triggered diseases such as Multiple Sclerosis (MS), patients with post-COVID-19 express the toxic envelope protein of the human endogenous retrovirus (HERV-W ENV) (Bjornevik et al., 2022; Charvet et al., 2023; Gim ´ enez-Orenga et al., 2022).”
Epstein-Barr Virus Seropositivity, Immune Dysregulation, and Mortality in Pediatric Sepsis
Sriram, A., Kernan, K. F., Qin, Y., Aldewereld, Z., Walton, A. H., Cabler, S. S., Storch, G. A., Cheynet, V., Brengel‐Pesce, K., Canna, S., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.27487 · Cited by 5
Manifestationen im Zentralnervensystem nach COVID-19
Gerhard, A., Prüß, H., & Franke, C. (2022) · Der Nervenarzt · doi:10.1007/s00115-022-01294-2 · Cited by 5
Le virus d’Epstein-Barr
Manet, É., & Gruffat, H. (2022) · médecine/sciences · doi:10.1051/medsci/2022051 · Cited by 5
EBV as the “gluten of MS” hypothesis provides a rationale for trialing antiviral therapies
Drosu, N. C., Giovannoni, G., Lechner‐Scott, J., Hawkes, C. H., Yeh, E. A., & Levy, M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104007 · Cited by 5
Infectious mononucleosis is associated with an increased incidence of NAFLD
Loosen, S., Kostev, K., Luedde, T., & Roderburg, C. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13911 · Cited by 5
Shaping the host cell environment with viral noncoding RNAs
Gorbea, C. M., Elhakiem, A., & Cazalla, D. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.12.008 · Cited by 5
Immunologic prediction of long COVID
Cron, R. Q. (2023) · Nature Immunology · doi:10.1038/s41590-022-01396-8 · Cited by 5
DNA Fragility and Repair: Some Personal Recollections
Lindahl, T. R. (2023) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-071322-020214 · Cited by 5
The intrinsically disordered protein glue of the myelin major dense line: Linking AlphaFold2 predictions to experimental data
Krokengen, O. C., Raasakka, A., & Kursula, P. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101474 · Cited by 7
Viral Immune signatures from cerebrospinal fluid extracellular vesicles and particles in HAM and other chronic neurological diseases
Pleet, M. L., Welsh, J. A., Stack, E. H., Cook, S. M., Johnson, D.-A., Killingsworth, B., Traynor, T. R., Clauze, A., Hughes, R., Monaco, M. C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235791 · Cited by 5
Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response
Domínguez‐Mozo, M. I., González‐Suarez, I., Villar, L. M., Costa‐Frossard, L., Villarrubia, N., Aladro, Y., Pilo, B., Montalbán, X., Comabella, M., Peño, I. C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1248182 · Cited by 5
Genetic influences on disease course and severity, 30 years after a clinically isolated syndrome
Sahi, N., Haider, L., Chung, K. K., Prados, F., Kanber, B., Samson, R. S., Thompson, A. J., Wheeler‐Kingshott, C. A. M. G., Trip, S. A., Brownlee, W. J., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad255 · Cited by 5
From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment
Raghib, M. F., & Bernitsas, E. (2023) · Biomedicines · doi:10.3390/biomedicines11113069 · Cited by 5
Is multiple sclerosis a glymphaticopathy?
Alghanimy, A., Giovannoni, G., Lechner‐Scott, J., Levy, M. L., Yeh, E. A., & Hawkes, C. H. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105141 · Cited by 5
Milk and multiple sclerosis: A possible link?
Morin, C. R., Baeva, M.-E., Hollenberg, M. D., & Brain, M. C. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105477 · Cited by 6
New insights in the pathogenic mechanism of multiple sclerosis: Is Epstein-Barr virus associated with optic nerve involvement?
Remolí-Sargues, L., Monferrer-Adsuara, C., López-Salvador, B., García–Villanueva, C., Gracia‐García, A., Castro-Navarro, V., & Cervera-Taulet, E. (2024) · European Journal of Ophthalmology · doi:10.1177/11206721241230567 · Cited by 5
Voiding Phase Dysfunction in Multiple Sclerosis
Ingram, C., Lincoln, J. A., & Khavari, R. (2024) · Urologic Clinics of North America · doi:10.1016/j.ucl.2024.01.005 · Cited by 5
The effects of urolithin A on poly I:C-induced microglial activation
Mingo, Y. B., Gabele, L., Lonnemann, N., Brône, B., Körte, M., & Hosseini, S. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1343562 · Cited by 5
“For instance, Bjornevik et al. recently found that Epstein-Bar virus (EBV) infection in humans increases the risk of multiple sclerosis (MS) by 32-fold, making EBV one of the most important triggers for the development of MS (Bjornevik et al., 2022).”
Background
Silent Infections are not So Silent: The Emerging Role of Combined Infections, Inflammation, and Vitamin Levels in OCD.
Marazziti, D., Massa, L., Carbone, M. G., Palermo, S., Arone, A., D'Angelo, G., Crivelli, N. S. B., Gurrieri, R., Perrone, P., Palagini, L., et al. (2024) · PubMed Central · doi:10.36131/cnfioritieditore20240101 · Cited by 6
Genetic and early life factors influence on time-to-multiple sclerosis diagnosis: A UK Biobank study
Nova, A., Caprio, G. D., Bernardinelli, L., & Fazia, T. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241257205 · Cited by 5
Molecular dissection of HERV-W dependent microglial- and astroglial cell polarization
Gruchot, J., Reiche, L., Werner, L., Herrero, F., Schira‐Heinen, J., Meyer, U., & Küry, P. (2024) · Microbes and Infection · doi:10.1016/j.micinf.2024.105382 · Cited by 5
Epstein–Barr virus flare: A multiple sclerosis attack
Msheik, A., Mokdad, Z. A., Hamed, F., Assi, F., Jibbawi, A., Saad, J. P., Mohanna, R., Khoury, A., Farhat, M., & Atat, R. (2024) · Surgical Neurology International · doi:10.25259/sni_457_2024 · Cited by 5
“[3,4,17,38] Although the literature masks B-cells’ neuroinvasion and its link to EBV, it remains not fully understood how the issue affects the stage and course of MS and a thorough examination is needed.”
Background
Viral insulin/IGF-like peptides inhibit IGF-1 receptor signaling to enhance viral replication
Chuard, A., Nesarajah, K., Danazumi, K., Reiners, K., Fa, Z., Levintov, L., Lubos, M., Žáková, L., Ruggera, R., McMenamin, S. K., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116149 · Cited by 5
Association between Epstein-Barr virus serological reactivation and psychological distress: a cross-sectional study of Japanese community-dwelling older adults
Yamanashi, H., Akabame, S., Miyata, J., Honda, Y., Nonaka, F., Shimizu, Y., Nakamichi, S., Kawashiri, S., Tamai, M., Arima, K., et al. (2022) · Aging · doi:10.18632/aging.204345 · Cited by 5
Comprehensively identifying Long Covid articles with human-in-the-loop machine learning
Leaman, R., Islamaj, R., Allot, A., Chen, Q.-Y., Wilbur, W., & Lu, Z.-Y. (2022) · Patterns · doi:10.1016/j.patter.2022.100659 · Cited by 5
Observed associations between indicators of socioeconomic status and risk of multiple sclerosis in Sweden are explained by a few lifestyle‐related factors
Alfredsson, L. S., Hillert, J. A., Olsson, T. P., & Hedström, A. K. (2023) · European Journal of Neurology · doi:10.1111/ene.15705 · Cited by 5
Decreased frequency of regulatory T cells and level of helios gene expression in secondary progressive multiple sclerosis patients: Evidence about the development of multiple sclerosis
Tarighi, M., Shahbazi, M., Saadat, P., Daraei, A., Khatir, A. A., Rahimifard, K., & Mohammadnia‐Afrouzi, M. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109797 · Cited by 5
EBV linked to multiple sclerosis
Toit, A. D. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00701-4 · Cited by 5
Molecular mechanisms associated with multiple sclerosis progression, severity and phenotypePreprint
Kosa, P. F., Lumbard, K., Wang, J., Liang, C., Masvekar, R., Kim, Y., Varosanec, M., Jennings, L. L., & Bielekova, B. (2022) · medRxiv · doi:10.1101/2022.10.14.22281095 · Cited by 5
Herpes viral infection and the multiple sclerosis prodrome: is HHV-6A infection a second hit?
Cree, B. (2023) · Brain · doi:10.1093/brain/awad418 · Cited by 5
Systems Analysis of Immune Changes after B-cell Depletion in Autoimmune Multiple SclerosisPreprint
Wei, J., Moon, J., Yasumizu, Y., Zhang, L., Radassi, K., Buitrago-Pocasangre, N., Deerhake, M. E., Strauli, N., Chan, A., Herman, A. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.07.576204 · Cited by 5
“…of effector Treg frequency both by transcriptomic and protein expression, it will be of interest to more precisely identify whether there are differences in specific myelin antigens and other antigens, as recent studies indicate EBV infection of B cells is associated with the onset of MS 56 .”
Background
What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease?
Brutkiewicz, R. R., Cao, W., Morgan, D., Reis, R. S. D., Suryadevara, V., Willette, A. A., Willette, S. A., Wyatt-Johnson, S. K., & Duggan, M. R. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.05.009 · Cited by 3

Authors: Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., & Ascherio, A.
Affiliations: Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Harvard University (US)
Brigham and Women's Hospital (US)
Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Uniformed Services University of the Health Sciences (US)
Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Corresponding author: Cortese, Marianna
Munger, Kassandra L.
Ascherio, Alberto
ORCID: Bjornevik, Kjetil
Cortese, Marianna
Healy, Brian C.
Mina, Michael J.
Leng, Yumei
Elledge, Stephen J.
Munger, Kassandra L.
Ascherio, Alberto
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2022-01-21
Volume: 375
Issue: 6578
Pages: 296-301
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.abj8222
OpenAlex: W4205972999
Cited by: 2,049
References: 51
Citations by year: 2026: 354 · 2025: 412 · 2024: 461 · 2023: 432 · 2022: 388
FWCI: 289.56
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
National Institute of Neurological Disorders and Stroke (R01NS042194, R01NS046635, R01NS103891)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Keywords: multiple sclerosis, Epstein-Barr virus, viral etiology, neurofilament light chain, neuroaxonal degeneration, cytomegalovirus, demyelinating disease, military personnel
MeSH terms: Antibodies, Viral, Cytomegalovirus, Herpesvirus 4, Human, Female, Humans, Longitudinal Studies, Male, Military Personnel, Multiple Sclerosis, Risk Factors, Cohort Studies, Biomarkers, Prevalence, Neurofilament Proteins, Age of Onset, Epstein-Barr Virus Infections, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks